HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Albert J van der Kogel Selected Research

Idoxuridine (Stoxil)

5/2010Histopathologic validation of 3'-deoxy-3'-18F-fluorothymidine PET in squamous cell carcinoma of the oral cavity.
4/2009No detectable hypoxia in malignant salivary gland tumors: preliminary results.
4/2008Tumour cell proliferation under hypoxic conditions in human head and neck squamous cell carcinomas.
5/200718F-FLT PET does not discriminate between reactive and metastatic lymph nodes in primary head and neck cancer patients.
2/2006Hypoxia in relation to vasculature and proliferation in liver metastases in patients with colorectal cancer.
7/2005Thymidine analogues to assess microperfusion in human tumors.
1/2005Colocalization of carbonic anhydrase 9 expression and cell proliferation in human head and neck squamous cell carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Albert J van der Kogel Research Topics

Disease

45Hypoxia (Hypoxemia)
09/2014 - 03/2002
42Neoplasms (Cancer)
12/2015 - 03/2002
17Squamous Cell Carcinoma of Head and Neck
12/2015 - 09/2002
10Head and Neck Neoplasms (Head and Neck Cancer)
11/2013 - 12/2002
9Carcinoma (Carcinomatosis)
02/2015 - 12/2002
5Neoplasm Metastasis (Metastasis)
02/2015 - 10/2005
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2010 - 04/2003
3Colorectal Neoplasms (Colorectal Cancer)
06/2006 - 10/2005
2Laryngeal Neoplasms (Laryngeal Cancer)
10/2013 - 05/2012
2Prolactinoma (Prolactinomas)
09/2013 - 04/2003
2Prostatic Neoplasms (Prostate Cancer)
05/2012 - 10/2010
2Spinal Cord Diseases
03/2010 - 09/2006
2Glioma (Gliomas)
07/2008 - 07/2005
2Fibrosarcoma
03/2008 - 04/2003
2Glioblastoma (Glioblastoma Multiforme)
08/2006 - 07/2006
2Necrosis
07/2006 - 03/2005
2Nausea
06/2002 - 03/2002
2Vomiting
06/2002 - 03/2002
1Breast Neoplasms (Breast Cancer)
09/2013
1Infarction (Infarctions)
07/2012
1Sarcoma (Soft Tissue Sarcoma)
06/2012

Drug/Important Bio-Agent (IBA)

24pimonidazoleIBA
09/2014 - 09/2002
14carbogenIBA
02/2015 - 03/2002
10Niacinamide (Nicotinamide)FDA LinkGeneric
02/2015 - 03/2002
10Carbonic Anhydrase IXIBA
02/2015 - 12/2002
8Oxygen (Dioxygen)IBA
12/2015 - 09/2002
8Proteins (Proteins, Gene)FDA Link
09/2013 - 06/2006
7Idoxuridine (Stoxil)FDA LinkGeneric
05/2010 - 01/2005
6Glucose (Dextrose)FDA LinkGeneric
09/2014 - 01/2002
6Phosphotransferases (Kinase)IBA
11/2013 - 09/2009
5Biological ProductsIBA
09/2014 - 01/2005
5Biomarkers (Surrogate Marker)IBA
09/2013 - 08/2005
5bisbenzimide ethoxide trihydrochloride (Hoechst 33342)IBA
05/2012 - 09/2002
4ErbB Receptors (EGF Receptor)IBA
09/2014 - 04/2009
4CCI 103FIBA
09/2013 - 07/2005
3Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
02/2014 - 10/2005
3ParaffinIBA
09/2013 - 02/2006
3fluoromisonidazoleIBA
08/2011 - 08/2006
2Hemoglobins (Hemoglobin)IBA
12/2015 - 01/2006
2Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
09/2014 - 03/2008
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
09/2014 - 11/2013
2Growth Factor ReceptorsIBA
11/2013 - 03/2013
2azomycinIBA
09/2013 - 12/2002
2Cetuximab (Erbitux)FDA Link
03/2013 - 11/2010
2AndrogensIBA
05/2012 - 10/2010
2Transcription Factors (Transcription Factor)IBA
01/2010 - 09/2009
2Erythropoietin Receptors (Erythropoietin Receptor)IBA
06/2007 - 08/2005
2Gadolinium DTPA (Magnevist)FDA Link
10/2005 - 07/2004
2Contrast MediaIBA
10/2005 - 04/2003
2GadoliniumIBA
07/2004 - 08/2002
1Lysosomal Membrane ProteinsIBA
09/2013
1Activating Transcription Factor 4IBA
09/2013
1Small Interfering RNA (siRNA)IBA
09/2013
1Dasatinib (BMS 354825)FDA Link
08/2013
11,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA
08/2013
1eIF-2 Kinase (eIF 2 Kinase)IBA
03/2013
1Peptide Initiation Factors (Initiation Factor)IBA
03/2013
1Reactive Oxygen Species (Oxygen Radicals)IBA
03/2013
1Cysteine (L-Cysteine)FDA Link
03/2013
1Double-Stranded RNA (RNA, Double Stranded)IBA
03/2013
1Glutathione (Reduced Glutathione)IBA
03/2013
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
03/2013
1MK 2206IBA
10/2012
1copper (II) diacetyl- di(N(4)- methylthiosemicarbazone)IBA
08/2011
1Eukaryotic Initiation Factor-4EIBA
06/2011
1VimentinIBA
06/2011
1Cadherins (E-Cadherin)IBA
06/2011
1Monoclonal AntibodiesIBA
11/2010
1Prostate-Specific Antigen (Semenogelase)IBA
10/2010
1motesanib diphosphateIBA
07/2010
1Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
01/2010
1Adenosine Triphosphate (ATP)IBA
06/2008
1Coloring Agents (Dyes)IBA
03/2008
1fluoroazomycin arabinosideIBA
03/2008
1ElementsIBA
03/2008
1OsteopontinIBA
06/2007
1alovudineIBA
05/2007
1Cytotoxins (Cytolysins)IBA
02/2007
1MisonidazoleIBA
02/2007
1Epidermal Growth Factor (EGF)IBA
01/2007
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2007
1Phenylalanine (L-Phenylalanine)FDA Link
09/2006
1Boron-10IBA
09/2006
1BoronIBA
09/2006
1FluorineIBA
06/2006
1Phosphorus (Red Phosphorus)IBA
06/2006
1Fluorouracil (Carac)FDA LinkGeneric
06/2006

Therapy/Procedure

30Radiotherapy
12/2015 - 03/2002
10Therapeutics
03/2013 - 08/2002
2Aftercare (After-Treatment)
07/2006 - 03/2006
2Drug Therapy (Chemotherapy)
06/2006 - 02/2006
2Metastasectomy
02/2006 - 10/2005
1Retreatment
07/2012
1Intravenous Injections
06/2012
1Castration
05/2012
1Microelectrodes
08/2011
1Re-Irradiation
03/2010
1Ligation
07/2008
1Electrodes (Electrode)
03/2008
1Lymph Node Excision (Lymph Node Dissection)
05/2007